← All Bills
SB212: Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.
IntroducedSenate
Introduced
In Committee
Passed Chamber
Passed Both
Signed
Plain-Language Summary
This bill aims to control prescription drug costs by creating a board and council to review medication prices. It also sets limits on how much insurance companies can pay for certain drugs.
Who This Affects
Kansans who rely on prescription medications will be affected, including those with chronic health conditions or disabilities who may struggle to afford their treatments.
Key Provisions
[object Object]
AI-generated summary · verify with full bill text
Timeline
Introduced
Tuesday, February 4, 2025
Last Action
Senate Referred to Committee on Financial Institutions and Insurance
Feb 5, 2025
Sponsors
- Dinah SykesDemocratcosponsor
Track This Bill
Get email alerts when this bill has new action.
Advertisement